Aelan Cell Technologies publishes new research identifying biomarkers that could serve as companion diagnostics for patients being treated with IL-2

Aelan identified the age of patients as a key determining factor in the efficacy of IL-2 cancer treatmentsAelan Cell Technologies, with an international research team, have released a study that… Source link